Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core
- PMID: 28537272
- PMCID: PMC5458082
- DOI: 10.1038/ncomms15462
Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core
Abstract
Polyglutamine expansion in the huntingtin protein is the primary genetic cause of Huntington's disease (HD). Fragments coinciding with mutant huntingtin exon1 aggregate in vivo and induce HD-like pathology in mouse models. The resulting aggregates can have different structures that affect their biochemical behaviour and cytotoxic activity. Here we report our studies of the structure and functional characteristics of multiple mutant htt exon1 fibrils by complementary techniques, including infrared and solid-state NMR spectroscopies. Magic-angle-spinning NMR reveals that fibrillar exon1 has a partly mobile α-helix in its aggregation-accelerating N terminus, and semi-rigid polyproline II helices in the proline-rich flanking domain (PRD). The polyglutamine-proximal portions of these domains are immobilized and clustered, limiting access to aggregation-modulating antibodies. The polymorphic fibrils differ in their flanking domains rather than the polyglutamine amyloid structure. They are effective at seeding polyglutamine aggregation and exhibit cytotoxic effects when applied to neuronal cells.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.Mol Cell. 2018 May 17;70(4):588-601.e6. doi: 10.1016/j.molcel.2018.04.007. Epub 2018 May 10. Mol Cell. 2018. PMID: 29754822 Free PMC article.
-
Huntingtin exon 1 fibrils feature an interdigitated β-hairpin-based polyglutamine core.Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1546-51. doi: 10.1073/pnas.1521933113. Epub 2016 Feb 1. Proc Natl Acad Sci U S A. 2016. PMID: 26831073 Free PMC article.
-
Autophagy preferentially degrades non-fibrillar polyQ aggregates.Mol Cell. 2024 May 16;84(10):1980-1994.e8. doi: 10.1016/j.molcel.2024.04.018. Mol Cell. 2024. PMID: 38759629
-
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.Biochem Soc Trans. 2024 Apr 24;52(2):719-731. doi: 10.1042/BST20230731. Biochem Soc Trans. 2024. PMID: 38563485 Free PMC article. Review.
-
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.Essays Biochem. 2014;56:167-80. doi: 10.1042/bse0560167. Essays Biochem. 2014. PMID: 25131594 Review.
Cited by
-
Abrogation of prenucleation, transient oligomerization of the Huntingtin exon 1 protein by human profilin I.Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5844-5852. doi: 10.1073/pnas.1922264117. Epub 2020 Mar 3. Proc Natl Acad Sci U S A. 2020. PMID: 32127471 Free PMC article.
-
New applications of solid-state NMR in structural biology.Emerg Top Life Sci. 2018 Apr 20;2(1):57-67. doi: 10.1042/ETLS20170088. Epub 2018 Feb 23. Emerg Top Life Sci. 2018. PMID: 29911185 Free PMC article.
-
Surface-Binding to Cardiolipin Nanodomains Triggers Cytochrome c Pro-apoptotic Peroxidase Activity via Localized Dynamics.Structure. 2019 May 7;27(5):806-815.e4. doi: 10.1016/j.str.2019.02.007. Epub 2019 Mar 14. Structure. 2019. PMID: 30879887 Free PMC article.
-
Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington's disease.Exp Biol Med (Maywood). 2019 Dec;244(17):1584-1595. doi: 10.1177/1535370219856620. Epub 2019 Jun 15. Exp Biol Med (Maywood). 2019. PMID: 31203656 Free PMC article. Review.
-
Integrative determination of the atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington's disease.bioRxiv [Preprint]. 2024 Sep 15:2023.07.21.549993. doi: 10.1101/2023.07.21.549993. bioRxiv. 2024. Update in: Nat Commun. 2024 Dec 30;15(1):10793. doi: 10.1038/s41467-024-55062-8 PMID: 37502911 Free PMC article. Updated. Preprint.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
